Gestational Trophoblastic Disease: Clinical Trials

6 trials for Gestational Trophoblastic Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Completed 6
Phase 22Completed 2

Follow Gestational Trophoblastic Disease: new trials by email Literature Review of Gestational Trophoblastic Disease trials Research Report on Gestational Trophoblastic Disease

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation
ravuconazole - Breast Cancer, Chronic Myeloproliferative Disorders
Phase 1 / Phase 2CompletedNational Institutes of Health Clinical Center (CC)2003-06-012012-03-08
Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions
recombinant adenovirus-hIFN-beta - Cancer
Phase 1CompletedAbramson Cancer Center at Penn Medicine2003-04-012020-05-13
Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon
beclomethasone dipropionate - Breast Cancer, Chronic Myeloproliferative Disorders
Phase 1 / Phase 2CompletedFred Hutchinson Cancer Center2000-07-012010-04-02
Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors
recombinant human thrombopoietin, carboplatin, etoposide - Cancer
Phase 1CompletedChildren's Oncology Group161998-11-012014-07-24
Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity
aminocamptothecin colloidal dispersion - Cancer
Phase 1CompletedNYU Langone Health201998-08-012011-03-28
Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors
recombinant interleukin-12 - Breast Cancer, Chronic Myeloproliferative Disorders
Phase 1CompletedIndiana University1997-10-012014-09-10

Narrower conditions

Breast Neoplasms (5)  ·  Carcinoma, Ovarian Epithelial (5)  ·  Testicular Neoplasms (5)  ·  Neuroblastoma (4)  ·  Blast Crisis (3)  ·  Burkitt Lymphoma (3)  ·  Hodgkin Disease (3)  ·  Leukemia (3)  ·  Leukemia, Hairy Cell (3)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (3)  ·  Leukemia, Myeloid, Accelerated Phase (3)  ·  Leukemia, Myeloid, Acute (3)  ·  Leukemia, Myeloid, Chronic-Phase (3)  ·  Lymphoma (3)

Broader conditions

Carcinoma (6)  ·  Endocrine Gland Neoplasms (6)  ·  Endocrine System Diseases (6)  ·  Female Urogenital Diseases (6)  ·  Female Urogenital Diseases and Pregnancy Complications (6)  ·  Genital Diseases (6)  ·  Gonadal Disorders (6)  ·  Neoplasms by Histologic Type (6)  ·  Neoplasms by Site (6)  ·  Neoplasms, Germ Cell and Embryonal (6)  ·  Neoplasms, Glandular and Epithelial (6)  ·  Pregnancy Complications (6)  ·  Pregnancy Complications, Neoplastic (6)  ·  Skin Diseases (6)  ·  Skin and Connective Tissue Diseases (6)

Interventions

Beclomethasone (1)  ·  Carboplatin (1)  ·  ER 30346 (1)  ·  Etoposide (1)  ·  Filgrastim (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Ifosfamide (1)  ·  Interleukin-12 Subunit p35 (1)  ·  Thrombopoietin (1)

Sponsors

Abramson Cancer Center at Penn Medicine (1)  ·  Children's Oncology Group (1)  ·  Fred Hutchinson Cancer Center (1)  ·  Indiana University (1)  ·  NYU Langone Health (1)  ·  National Institutes of Health Clinical Center (CC) (1)

Countries

United States (6)  ·  Australia (1)

Top investigators

Daniel H. Sterman, MD (1)  ·  David Hockenbery, MD (1)  ·  Franco M. Muggia, MD (1)  ·  Michael J. Robertson, MD (1)  ·  Mitchell S. Cairo, MD (1)  ·  Thomas J. Walsh, MD (1)

Results publications

PMID 15814645, PMID 20068553

NIH funding

P30CA016087 (1), U01CA076642 (1)